Frito-Lay, a global snack giant, is grappling with a major crisis after the Food and Drug Administration (FDA) upgraded the recall of its Tostitos Cantina Traditional Yellow Corn Tortilla Chips to Class I status on April 9, 2025. This top-tier classification, the most severe in food safety recalls, signals a “reasonable probability” that consuming the product could lead to “serious adverse health consequences or death.” The issue stems from undeclared milk in packages meant to contain only corn chips, posing a lethal risk to those with milk allergies. The affected 13-ounce (368-gram) bags, with a “Guaranteed Fresh” date of May 20, 2025, have been pulled from shelves across the United States and Canada following reports of allergic reactions.
The recall began on March 26 when Frito-Lay discovered that some Tostitos Cantina bags were mistakenly filled with nacho cheese-flavored corn chips, which include milk powder—an allergen not listed on the packaging. Initially deemed a moderate concern, the situation escalated after the FDA confirmed the danger, prompting urgent action. About 25,000 units, identified by specific manufacturing codes, are involved, affecting a staple snack in millions of households. Consumers are urged to discard or return the product immediately, while Frito-Lay, a PepsiCo subsidiary, races to remove the tainted batches. In Brazil, where Tostitos has a smaller footprint, no affected lots have been reported, but the news has sparked safety concerns among local snack fans.
This Class I recall exposes flaws in Frito-Lay’s production chain and reignites debates over food labeling accuracy. With milk allergies impacting roughly 6.1 million Americans—2% of adults and up to 7% of kids—the stakes are high. The FDA’s move underscores the potential for severe reactions like anaphylaxis, and Frito-Lay now faces a reputational hit alongside logistical challenges. This report dives into the recall’s origins, health risks, market fallout, and the company’s response to one of its toughest tests in recent years.
How the recall started
Frito-Lay kicked off the recall on March 26 after customers flagged an odd taste in their Tostitos Cantina chips. Internal checks revealed a mix-up at a U.S. plant, where nacho cheese corn chips—laden with milk—were packed into bags labeled as plain corn tortilla chips. The error slipped past initial quality controls, allowing the mislabeled products to hit stores. The company pinpointed the issue to its Plano, Texas facility, one of PepsiCo’s largest, and halted production of the affected line to investigate.
The recalled bags are Tostitos Cantina Traditional Yellow Corn Tortilla Chips, 13 ounces, with UPC 28400 52848 and a “Guaranteed Fresh” date of May 20, 2025. They bear manufacturing codes like 471106504, 18 13:XX or 471106505, 85 13:XX, where “XX” ranges from 30 to 55. Frito-Lay estimates 25,000 bags reached the U.S. and Canada, key markets where Tostitos is a top seller. The initial recall aimed to limit exposure, but early underestimation of the risk led to the FDA’s Class I upgrade on April 9 after allergic reactions surfaced.
- Product: Tostitos Cantina Traditional Yellow Corn Tortilla Chips
- Size: 13 ounces (368 grams)
- UPC: 28400 52848
- Freshness date: May 20, 2025
- Affected codes: 471106504, 18 13:XX; 471106505, 85 13:XX; others
Health risks from undeclared milk
Undeclared milk in the Tostitos Cantina chips poses a dire threat to those with milk allergies or intolerances. Milk ranks among the FDA’s top eight allergens, alongside peanuts and shellfish, triggering reactions from mild rashes to life-threatening anaphylaxis. In the U.S., about 0.6% of adults and 2.5% of kids—roughly 6.1 million people—have this allergy, with similar rates worldwide.
Allergic responses can strike within minutes, causing breathing difficulties, throat swelling, and plummeting blood pressure, often requiring epinephrine. In 2024, food-related anaphylaxis led to 4,200 U.S. hospitalizations, with milk tied to 20% of cases. For Frito-Lay, the mislabeling is a critical lapse, as Tostitos Cantina was marketed as dairy-free, misleading allergy sufferers who trusted the packaging. Lactose intolerance, affecting 68% of the global population, adds milder risks like bloating and diarrhea, further underscoring the need for clear labels.
Frito-Lay’s first response
Frito-Lay sprang into action on March 26, issuing a voluntary recall notice after pinpointing the milk contamination. Quality teams descended on the Plano plant, suspending Tostitos Cantina production and isolating nacho cheese chips to prevent further mix-ups. The company urged consumers to toss or return the affected bags, offering full refunds or product swaps.
Major retailers like Walmart, Target, and Kroger began pulling the chips that day, aided by Frito-Lay’s logistics support. Social media alerts spread the word, but the initial response downplayed the severity, treating it as a routine recall. Only after consumer reports of allergic reactions did the FDA step in, pushing the recall to Class I on April 9, revealing the true scope of the danger.
Why the recall hit Class I status
The FDA’s April 9 upgrade to Class I status marked a turning point. Reserved for products with serious or fatal risks, Class I differs from Class II (temporary issues) and Class III (low risk). The shift followed reports of allergic reactions, including a child’s hospitalization in Ohio after anaphylaxis from eating the chips. FDA tests confirmed milk proteins in the affected batches at levels high enough to trigger severe responses in allergic individuals.
The agency estimates 1% of Tostitos Cantina buyers—potentially thousands—face risk, given milk allergy prevalence. Frito-Lay ramped up efforts, issuing broader warnings and notifying over 3 million loyalty program members. Of 152 Class I recalls in the U.S. in 2024, this is the 12th tied to undeclared allergens, spotlighting a rising industry challenge.
Market and brand fallout
The recall rattled the $34 billion U.S. snack market, where Frito-Lay holds a 60% share, raking in over $19 billion in 2024. PepsiCo’s stock dipped 1.8% on April 9 in New York, as investors weighed the recall’s $10-15 million cost in logistics, refunds, and lost sales. Smaller retailers saw a 5% drop in other Frito-Lay sales—like Doritos and Cheetos—amid consumer wariness.
Social media erupted with #TostitosRecall and #FritoLayFail, denting a brand synonymous with snacks for 90 years. Rivals like Utz and Pringles seized the moment, touting their safety credentials. In Brazil, where Frito-Lay’s reach is smaller, Tostitos’ limited presence softens the blow, but imported snack fans are on edge, though no tainted lots have surfaced locally.
Frito-Lay’s crisis containment efforts
Frito-Lay escalated its response post-Class I upgrade. Production at Plano remains paused, with all 30 U.S. plants—churning out 1.2 billion snack bags yearly—under review. New sorting machines and allergen training for 5,000 workers aim to prevent repeats. A 24/7 hotline logged 10,000 calls in 48 hours, handling refunds and reaction reports, while a TV and digital campaign reaffirms safety commitments.
Retailers received field teams to yank 80% of the 25,000 affected bags by April 9, targeting full removal by week’s end. Compensation for allergic reactions is promised, though figures are undisclosed. In Brazil, PepsiCo monitors local stocks, ensuring no overlap with U.S. production lines.
Allergy sufferers hit hardest
For the 1.5 million U.S. adults and 4.6 million kids with milk allergies, the recall is a stark warning. An Ohio child’s ICU stay after eating the chips underscores the stakes—30% of 2024 U.S. anaphylaxis deaths tied to hidden allergens. Allergy groups praised the FDA’s speed but slammed Frito-Lay’s initial oversight. In Brazil, 1.2% of the population shares this allergy, fueling label scrutiny among parents.
Snack industry backdrop
Frito-Lay’s woes hit a $34 billion U.S. snack sector in 2024, where it leads despite growing competition from health-focused brands like Popchips, up 8% in share. Past recalls—like Kellogg’s 2023 Corn Pops issue (Class II)—pale beside this Class I case. FDA inspections rose 42% in 2025, targeting allergens. In Brazil, a 12% market growth favors local Elma Chips (PepsiCo), but the recall casts a shadow.
Frito-Lay’s next moves
Production resumes post-May with $5 million in new Plano equipment. Labels will get bolder allergen warnings by June, and independent tests will verify safety. A 20% discount campaign through June aims to win back trust. PepsiCo’s July earnings may show a 2% snack revenue dip, but swift action could cap long-term harm. Brazil’s PepsiCo plans local safety ads for Ruffles and Cheetos.
Lessons for food makers
Undeclared allergens drove 45% of 2024 U.S. recalls, pushing firms like Nestlé to QR-code tracking. Frito-Lay follows suit, eyeing a 2026 digital system. Segregated lines, per FDA advice, are next. Brazil’s 18 recalls in 2024 echo the need for tighter rules.
Brazil’s consumer ripple
No tainted Tostitos hit Brazil, where Frito-Lay focuses on Ruffles and Doritos, but imported snack queries spiked online. With 1.2% milk-allergic and 30% lactose-intolerant, trust wavers. Local brands like Yoki gained 3% in April sales, while PepsiCo reassures via campaigns.
Frito-Lay’s roadmap ahead
Key dates include:
- April 15: Full U.S./Canada recall wrap-up
- April 30: Plano failure report
- May 20: Tostitos production restart
- July: PepsiCo quarterly results
- August: Tostitos relaunch campaign
These steps will shape Frito-Lay’s recovery from this high-stakes recall.